Chronic fatigue syndrome Market, Size, Share, Growth, Trends, Insight and Industry Forecast, 2021-2028

SKU: DMPH3738 | Last Updated On: Aug 25 2021 | No. of Pages: 180 | Available Formats

Global Chronic fatigue syndrome Market Expected to reach a high CAGR By 2028: DataM Intelligence

Global Chronic fatigue syndrome Market is segmented By Type (Immune Enhancer & Antivirals, Sleep Enhancing, CNS Stimulants, Others), By End-User (Hospitals, Clinics, Research Institutes), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2021-2028

Market Overview

The global chronic fatigue syndrome market size was valued US$ XX billion in 2020 and is estimated to reach US$ XX billion by 2028, growing at a CAGR of XX % during the forecast period (2021-2028).

Chronic fatigue syndrome is also called myalgic encephalomyelitis, a chronic disorder associated with long-term fatigue and tiredness in patients. Any condition cannot define these symptoms.

Source: Data M Intelligence Analysis (2020)

Market Dynamics

 Increasing techniques to find the symptoms of chronic fatigue syndrome (CFS) is expected to drive the market's growth.

According to the BMJ Journal, on February 1, 2021. They have explored the relationship between chronic fatigue syndrome (CFS) and fibromyalgia (FM) using a quasi-experimental design. Invariance was confirmed except for the American CDC Symptom Inventory, Fibromyalgia Impact Questionnaire and Hospital Anxiety and Depression Scale (p<0.05) based on five questions. Consequently, it was incorrect to conclude differences. Therefore, the Syndrome Model was created.  Consequently, it is combined with these three questionnaires, increasing the data points, to create this new measurable model. Results confirmed no significant differences between groups (p=0.07 (p<0.05)). Thus, participants responded similarly to the questionnaire, confirming the same symptom experience. It is important to consider this in context with differing criteria and management guidelines, as this may influence diagnosis and patient management trajectory. With the biomedical cause currently unclear, the symptom experience and the impact on quality of life are important. These findings are meaningful for patients, clinicians and policy development and support the requirement for future research. Therefore, from the above statements, it is expected to drive the market's growth in the forecast period.

The increasing prevalence of chronic fatigue syndrome (CFS) is expected to drive the market's growth.

According to the Medicina, in 2021. Prevalence rates have been estimated as between 0.1 and 0.7% and the incidence rate as 0.015 new cases/1000-year. Moreover, it could represent between 1 million and over 5 million people, probably around 3 million, in the European continent living with chronic fatigue syndrome (CFS). However, there are no European-wide estimates of disease burden. Many people will have chronic fatigue for other reasons, and many of them are significantly hindered. At least 2/3 of the cases are in women, with young people in their most productive phases of life being preferentially affected. However, ME/CFS has been reported in all age groups. The quality of life of those with ME/CFS is on average lower than with other chronic or disabling diseases, such as multiple sclerosis, cancer, rheumatoid arthritis, depression, diabetes, epilepsy, or cystic fibrosis. Thus, the above factors are expected to drive the growth of the market in the forecast period.

The Economic Impacts of Chronic Fatigue Syndrome in an Australian Cohort are expected to hamper the market's growth.

According to the research article, on 21 August 2020. A cost of illness study is conducted to estimate Australian cost data for individuals with a ME/CFS diagnosis as determined by the Canadian Consensus Criteria (CCC), International Consensus Criteria (ICC), and the 1994 CDC Criteria (Fukuda). Moreover, Survey participants identified from a research registry database provided a self-report of expenditure associated with ME/CFS-related healthcare across a 1-month timeframe between 2017 and 2019. Additionally, the mean annual cost of healthcare-related expenditure and associated income loss among survey participants meeting diagnostic criteria for ME/CFS is estimated at $14.5 billion. For direct OOP and Government health care expenditure, high average costs were related to medical practitioner attendance, diagnostics, natural medicines, and device expenditure, with an average attendance of 10.6 referred attendances per annum and 12.1 GP visits per annum related specifically to managing ME/CFS. Thus, from the above statements, the market is expected to get hampered in the forecast period.

Chronic fatigue syndrome Market Industry Analysis

PESTAnalysis: SupplyChain:

COVID-19 Impact Analysis

The COVID-19 pandemic has caused overwhelming challenges in healthcare worldwide. According to the study conducted by the Gavi on 19 June 2020, which is done in Hong Kong, 40% of people recovering from SARS still had chronic fatigue symptoms 3.5 years after being diagnosed. Viral infections such as SARS and Epstein-Barr virus trigger chronic fatigue syndrome that can last for months or years. Moreover, COVID-19 has complicated the treatment of chronic fatigue symptoms in patients. Research into the new disease is benefiting from insights gained over years of chronic fatigue syndrome research.

Further researches are needed to recognize the advanced planning and rapid responses to reduce the impact of the pandemic as stakeholders are increasingly searching for newer approaches towards diagnosing and curing patients affected by the COVID-19.

Segment Analysis

Sleep Enhancing segment is expected to hold the largest market share in this market segment.

The sleep-enhancing segment held the largest market share in 2020. The segment's growth is attributed to increasing sleep disorders, and increasing genetic susceptibility in patients with CFS is expected to boost the market in the forecast period. For instance, according to the National Center for Biotechnology Information, on June 11, 2021. There has been increasing evidence supports the role of genetic susceptibility in patients with CFS. Family history studies of chronic fatigue syndrome have shown significantly higher family members rates of the patient reporting CFS or similar fatigue-like symptoms. Studies from the twin registry also have shown increased familial and genetic predisposition of the condition. A study has reported variability in the expression of specific genes in patients with CFS, particularly after exercise, which affects the metabolism and immune responses. At the same time, another study has shown a linkage between CFS, specific genetic mutations, and viral infections.

Moreover, non-restorative sleep despite sufficient or extended total sleep time is one of the major clinical diagnostic criteria; however, the underlying cause of this symptom is unknown. Additionally, polysomnographic and other objective measures of sleep have observed few variations in sleep parameters between CFS/ME patients and healthy controls, although some discrepancies exist.

This lack of significant objective differences differs from the common subjective complaints of disturbed and unrefreshed sleep by CFS/ME patients. The emergence of new, more sensitive techniques that examine the microstructure of sleep shows promise for detecting differences in sleep between patients and healthy individuals. There is preliminary evidence that alterations in sleep stage transitions and sleep instability, and other physiological mechanisms, such as heart rate variability and altered cortisol profiles, may be evident. Thus, from the above factors, the segment is expected to hold the largest market segment.

Source: DataM Intelligence Analysis (2020)

Geographical Analysis

North America region holds the largest market share in the global Chronic fatigue syndrome market.

North America dominated the market and accounted for the largest revenue share in 2020. The region's growth is benefited due to changing lifestyles, increasing healthcare expenditure, and increasing cases of chronic fatigue syndrome in adolescents are expected to boost the market in the forecast period. For instance, according to the Journal of Cambridge University published on 1 April 2020. Chronic fatigue syndrome (CFS) has a major impact on functioning. However, no validated measures of functioning for this population exist. They aimed o establish the psychometric properties of the 5-item School and Social Adjustment Scale (SSAS) and the 10-item Physical Functioning Subscale of the SF-36 in adolescents with CFS.

Moreover, measures were completed by adolescents with CFS (n = 121). Thus, both measures are reliable and valid and provide brief measures for assessing these important outcomes. The Physical Functioning Subscale can be used as two subscales in adolescents with CFS. Additionally, the rise in the availability of funds for research, a huge patient population, a well-developed healthcare sector and government support for research & development in this region hold the largest market share.

Source: DataM Intelligence Analysis (2020)

Competitive Landscape

The chronic fatigue syndrome market is vast with presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Hemispherx Biopharma, Inc., Torrent Pharmaceuticals Ltd., Fortis Healthcare, F. Hoffmann-La Roche Ltd, K-PAX Pharmaceuticals, Inc., Dr Batra's, London School of Hygiene L, Tropical Medicine – CureME. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the chronic fatigue syndrome market globally.

Chronic fatigue syndrome Market Key Companies to Watch

Torrent Pharmaceuticals Limited:

Overview:

­Torrent Pharmaceuticals Ltd is an Indian multinational pharmaceutical company owned by Torrent Group, headquartered in Ahmedabad, India. It was promoted by U. N. Mehta, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd. Moreover, the company is operated in more than 40 countries with over 2000 product registrations globally. It is active in the therapeutic areas of cardiovascular (CV), central nervous system (CNS), gastrointestinal, diabetology, anti-infective and pain management segments. It has also forayed into the therapeutic segments of nephrology and oncology while also strengthening its focus on gynecology and pediatric segments.

Product Portfolio:

Torrent Pharmaceuticals Ltd. has continuously set new standards for continuous manufacturing of Alcohol Deaddiction, Anti-Depressant, Anti-Epileptic drugs, Stimulants and other medications.

Why Purchase the Report?

  • Visualize the composition of the chronic fatigue syndrome market segmentation by type, End-User and region highlighting the key commercial assets and players.
  • Identify commercial opportunities in advanced delayed- release capsules market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of chronic fatigue syndrome market- level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global chronic fatigue syndrome market report would provide an access to an approx.41 market data table, 39 figures and 200pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Market Segmentation

Global Chronic fatigue syndrome Market – By Type

  • Immune Enhancer & Antivirals
  • Sleep Enhancing
  • CNS Stimulants
  • Others

Global Chronic fatigue syndrome Market – By End-User

  • Hospitals
  • Clinics
  • Research Institutes

Global Chronic fatigue syndrome Market - By Region

  • North America
  • South America
  • Europe
  • Asia
  • Middle East & Africa

Table of Contents

  1. Global Chronic fatigue syndrome Market Methodology and Scope

    1. Research Methodology
    2. Research Objective and Scope of the Report
  2. Global Chronic fatigue syndrome Market – Market Definition and Overview

  3. Global Chronic fatigue syndrome Market – Executive Summary

    1. Market Snippet by Type
    2. Market Snippet by End-User
    3. Market Snippet by Region
  4. Global Chronic fatigue syndrome Market – Market Dynamics

    1. Market Impacting Factors
      1. Drivers
        1. Increasing techniques to find the symptoms of chronic fatigue syndrome (CFS) is expected to drive the market's growth.
        2. The increasing prevalence of chronic fatigue syndrome (CFS) is expected to drive the market's growth.
      2.  Restraints:
        1. The Economic Impacts of Chronic Fatigue Syndrome in an Australian Cohort are expected to hamper the market's growth.
      3. Opportunity
      4. Impact Analysis
  5. Global Chronic fatigue syndrome Market – Industry Analysis

    1. Porter's Five Forces Analysis
    2. Epidemiology Analysis
    3. Supply Chain Analysis
    4. Pricing Analysis
    5. Regulatory Analysis
    6. Reimbursement Analysis
    7. Unmet Needs
  6. Global Chronic fatigue syndrome Market – COVID-19 Analysis

    1. Analysis of Covid-19 on the Market
      1. Before COVID-19 Market Scenario
      2. Present COVID-19 Market Scenario
      3. After COVID-19 or Future Scenario
    2. Pricing Dynamics Amid Covid-19
    3. Demand-Supply Spectrum
    4. Government Initiatives Related to the Market During Pandemic
    5. Manufacturers Strategic Initiatives
    6. Conclusion 
  7. Global Chronic fatigue syndrome Market – By Type

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      2. Market Attractiveness Index, By Type Segment
    2. Immune Enhancer & Antivirals*
      1. Introduction
      2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
    3. Sleep Enhancing
    4. CNS Stimulants
    5. Others
  8. Global Chronic fatigue syndrome Market – By End-User

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
      2. Market Attractiveness Index, By End-User Segment
    2. Hospitals*
      1. Introduction
      2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
    3. Clinics
    4. Research Institutes
  9. Global Chronic fatigue syndrome Market – By Region

    1. Introduction
      1. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
      2. Market Attractiveness Index, By Region
    2. North America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. U.S.
        2. Canada
        3. Mexico
    3. Europe
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Germany
        2. U.K.
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
    4. South America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Brazil
        2. Argentina
        3. Rest of South America
    5. Asia Pacific
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. China
        2. India
        3. Japan
        4. Australia
        5. Rest of Asia Pacific
    6. Middle East and Africa
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  10. Global Chronic fatigue syndrome Market – Competitive Landscape

    1. Key Developments and Strategies
    2. Company Share Analysis
    3. Type Benchmarking
    4. List of Key Companies to Watch
    5. List of Company with disruptive technology
    6. List of Start Up Companies
  11. Global Chronic fatigue syndrome Market- Company Profiles

    1. Torrent Pharmaceuticals Ltd.*
      1. Company Overview
      2. Type Portfolio and Description
      3. Key Highlights
      4. Financial Overview
    2. Hemispherx Biopharma, Inc.
    3. Tropical Medicine – CureME
    4. Fortis Healthcare
    5. F. Hoffmann-La Roche Ltd
    6. K-PAX Pharmaceuticals, Inc. 
    7. Dr Batra's
    8. London School of Hygiene (*LIST NOT EXHAUSTIVE)
  12. Global Chronic fatigue syndrome Market – DataM

    1. Appendix
    2. About Us
    3. Contact Us

List of Tables & Figures

List of Tables

Table1      Global Chronic fatigue syndrome Market Value, By Type, 2020, 2024 & 2028 ($ Million)

Table2      Global Chronic fatigue syndrome Market Value, By End-User, 2020, 2024 & 2028 ($ Million)

Table3      Global Chronic fatigue syndrome Market Value, By Region, 2020, 2024 & 2028 ($ Million)

Table4     Global Chronic fatigue syndrome Market Value, By Type, 2020, 2024 & 2028 ($ Million)

Table5      Global Chronic fatigue syndrome Market Value, By Type, 2018-2028 ($ Million)

Table6    Global Chronic fatigue syndrome Market Value, By End-User, 2020, 2024 & 2028 ($ Million)

Table7      Global Chronic fatigue syndrome Market Value, By End-User, 2018-2028 ($ Million)

Table8     Global Chronic fatigue syndrome Market Value, By Region, 2020, 2024 & 2028 ($ Million)

Table9     Global Chronic fatigue syndrome Market Value, By Region, 2018-2028 ($ Million)

Table10   North America Chronic fatigue syndrome Market Value, By Type, 2018-2028 ($ Million)

Table11    North America Chronic fatigue syndrome Market Value, By End-User, 2018-2028 ($ Million)

Table12    North America Chronic fatigue syndrome Market Value, By Country, 2018-2028 ($ Million)

Table13    South America Chronic fatigue syndrome Market Value, By Type, 2018-2028 ($ Million)

Table14    South America Chronic fatigue syndrome Market Value, By End-User, 2018-2028 ($ Million)

Table15    South America Chronic fatigue syndrome Market Value, By Country, 2018-2028 ($ Million)

Table16    Europe Chronic fatigue syndrome Market Value, By Type, 2018-2028 ($ Million)

Table17    Europe Chronic fatigue syndrome Market Value, By End-User, 2018-2028 ($ Million)

Table18    Europe Chronic fatigue syndrome Market Value, By Country, 2018-2028 ($ Million)

Table19    Asia-Pacific Chronic fatigue syndrome Market Value, By Type, 2018-2028 ($ Million)

Table20   Asia-Pacific Chronic fatigue syndrome Market Value, By End-User, 2018-2028 ($ Million)

Table21    Asia-Pacific Chronic fatigue syndrome Market Value, By Country, 2018-2028 ($ Million)

Table22   Middle East & Africa Chronic fatigue syndrome Market Value, By Type, 2018-2028 ($ Million)

Table23   Middle East & Africa Chronic fatigue syndrome Market Value, By End-User, 2018-2028 ($ Million)

Table24   Fortis Healthcare: Overview

Table25   Fortis Healthcare: Product Portfolio

Table26   Fortis Healthcare: Key Developments

Table27   F. Hoffmann-La Roche Ltd: Overview

Table28   F. Hoffmann-La Roche Ltd: Product Portfolio

Table29   F. Hoffmann-La Roche Ltd: Key Developments

Table30   K-PAX Pharmaceuticals, Inc.: Overview

Table31    K-PAX Pharmaceuticals, Inc.: Product Portfolio

Table32   K-PAX Pharmaceuticals, Inc.: Key Developments

Table33   Dr Batra's: Overview

Table34   Dr Batra's: Product Portfolio

Table35   Dr Batra's: Key Developments

Table36   London School of Hygiene L: Overview

Table37   London School of Hygiene L: Product Portfolio

Table38 London School of Hygiene L: Key Developments

Table39   Tropical Medicine - CureME: Overview

Table40   Tropical Medicine - CureME: Product Portfolio

Table41    Tropical Medicine - CureME: Key Developments

List of Figures

Figure1    Global Chronic fatigue syndrome Market Share, By Type, 2019 & 2027 (%)

Figure2    Global Chronic fatigue syndrome Market Share, By End-User, 2019 & 2027 (%)

Figure3    Global Chronic fatigue syndrome Market Share, By Region, 2019 & 2027 (%)

Figure4    Global Chronic fatigue syndrome Market Value, 2018-2028 ($ Million)

Figure5    Global Chronic fatigue syndrome Market Y-o-Y Growth, By Type, 2019-2027 (%)

Figure6    Immune Enhancer & Antivirals: Global Chronic fatigue syndrome Market Value, 2018-2028 ($ Million)

Figure7    Sleep Enhancing: Global Chronic fatigue syndrome Market Value, 2018-2028 ($ Million)

Figure8    CNS Stimulants: Global Chronic fatigue syndrome Market Value, 2018-2028 ($ Million)

Figure9    Others: Global Chronic fatigue syndrome Market Value, 2018-2028 ($ Million)

Figure10  Global Chronic fatigue syndrome Market Y-o-Y Growth, By End-User, 2019-2027 (%)

Figure11   Hospitals: Global Chronic fatigue syndrome Market Value, 2018-2028 ($ Million)

Figure12  Clinics: Global Chronic fatigue syndrome Market Value, 2018-2028 ($ Million)

Figure13  Research Institutes: Global Chronic fatigue syndrome Market Value, 2018-2028 ($ Million)

Figure14  Global Chronic fatigue syndrome Market Y-o-Y Growth, By Region, 2019-2027 (%)

Figure15  North America Chronic fatigue syndrome Market Value, 2018-2028 ($ Million)

Figure16  North America Chronic fatigue syndrome Market Share, By Type, 2019 & 2027 (%)

Figure17   North America Chronic fatigue syndrome Market Share, By End-User, 2019 & 2027 (%)

Figure18  North America Chronic fatigue syndrome Market Share, By Country, 2019 & 2027 (%)

Figure19  South America Chronic fatigue syndrome Market Value, 2018-2028 ($ Million)

Figure20  South America Chronic fatigue syndrome Market Share, By Type, 2019 & 2027 (%)

Figure21  South America Chronic fatigue syndrome Market Share, By End-User, 2019 & 2027 (%)

Figure22  South America Chronic fatigue syndrome Market Share, By Country, 2019 & 2027 (%)

Figure23  Europe Chronic fatigue syndrome Market Value, 2018-2028 ($ Million)

Figure24  Europe Chronic fatigue syndrome Market Share, By Type, 2019 & 2027 (%)

Figure25  Europe Chronic fatigue syndrome Market Share, By End-User, 2019 & 2027 (%)

Figure26  Europe Chronic fatigue syndrome Market Share, By Country, 2019 & 2027 (%)

Figure27  Asia-Pacific Chronic fatigue syndrome Market Value, 2018-2028 ($ Million)

Figure28  Asia-Pacific Chronic fatigue syndrome Market Share, By Type, 2019 & 2027 (%)

Figure29  Asia-Pacific Chronic fatigue syndrome Market Share, By End-User, 2019 & 2027 (%)

Figure30  Asia-Pacific Chronic fatigue syndrome Market Share, By Country, 2019 & 2027 (%)

Figure31  Middle East & Africa Chronic fatigue syndrome Market Value, 2018-2028 ($ Million)

Figure32  Middle East & Africa Chronic fatigue syndrome Market Share, By Type, 2019 & 2027 (%)

Figure33  Middle East & Africa Chronic fatigue syndrome Market Share, By End-User, 2019 & 2027 (%)

Figure34  Fortis Healthcare: Financials

Figure35  F. Hoffmann-La Roche Ltd: Financials

Figure36  K-PAX Pharmaceuticals, Inc. : Financials

Figure37  Dr Batra's: Financials

Figure38  London School of Hygiene L: Financials

Figure39  Tropical Medicine - CureME: Financials

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report



Get your free sample proposal with a single click!

linkedinpinterest